Patents Assigned to Pharmacin Corporation
  • Process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate
    Patent number: 5118799
    Abstract: This invention relates to a process for converting crystalline erythromycin ethylsuccinate into stable amorphous erythromycin ethylsuccinate, and to the use of this stable amorphous ethylsuccinate in pharmaceutical compositions which may possibly contain pharmacologically acceptable excipients, surfactants and the like.
    Type: Grant
    Filed: October 27, 1989
    Date of Patent: June 2, 1992
    Assignee: Pharmacin Corporation
    Inventor: Jean F. Rossignol